YiChang HEC ChangJiang Pharmaceutical Gestione
Gestione criteri di controllo 3/4
YiChang HEC ChangJiang Pharmaceutical Il CEO è Juncai Jiang, nominato in May2015, e ha un mandato di 9.5 anni. la retribuzione annua totale è CN¥ 2.57M, composta da 18.7% di stipendio e 81.3% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.008% delle azioni della società, per un valore di HK$ 623.81K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 7.3 anni e 7.3 anni.
Informazioni chiave
Juncai Jiang
Amministratore delegato
CN¥2.6m
Compenso totale
| Percentuale dello stipendio del CEO | 18.7% |
| Mandato del CEO | 9.5yrs |
| Proprietà del CEO | 0.008% |
| Durata media del management | 7.3yrs |
| Durata media del Consiglio di amministrazione | 7.3yrs |
Aggiornamenti recenti sulla gestione
Recent updates
YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Strong Profits May Be Masking Some Underlying Issues
Oct 07
Should You Be Adding YiChang HEC ChangJiang Pharmaceutical (HKG:1558) To Your Watchlist Today?
Sep 19YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Popularity With Investors Under Threat As Stock Sinks 26%
May 29Do YiChang HEC ChangJiang Pharmaceutical's (HKG:1558) Earnings Warrant Your Attention?
Apr 23YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) P/S Is Still On The Mark Following 33% Share Price Bounce
Mar 01Investors Appear Satisfied With YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Prospects As Shares Rocket 33%
Mar 01YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Business Is Trailing The Industry But Its Shares Aren't
Jan 03YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Could Easily Take On More Debt
Sep 25Does YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Have A Healthy Balance Sheet?
Nov 25Is YiChang HEC ChangJiang Pharmaceutical (HKG:1558) A Risky Investment?
Mar 23Does This Valuation Of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Imply Investors Are Overpaying?
Oct 29Here's Why YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Has A Meaningful Debt Burden
Apr 13YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Analysts Just Cut Their EPS Forecasts Substantially
Mar 23YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Share Price Is Down 55% Over The Past Three Years.
Mar 13YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Is Growing Earnings But Are They A Good Guide?
Feb 20
Do Institutions Own YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Shares?
Feb 02YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Dec 26Key Things To Watch Out For If You Are After YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) 5.1% Dividend
Dec 13What Type Of Returns Would YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Nov 30Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥2b |
| Mar 31 2024 | n/a | n/a | CN¥2b |
| Dec 31 2023 | CN¥3m | CN¥482k | CN¥2b |
| Sep 30 2023 | n/a | n/a | CN¥2b |
| Jun 30 2023 | n/a | n/a | CN¥1b |
| Mar 31 2023 | n/a | n/a | CN¥608m |
| Dec 31 2022 | CN¥1m | CN¥600k | CN¥77m |
| Sep 30 2022 | n/a | n/a | -CN¥18m |
| Jun 30 2022 | n/a | n/a | -CN¥113m |
| Mar 31 2022 | n/a | n/a | -CN¥351m |
| Dec 31 2021 | CN¥1m | CN¥490k | -CN¥588m |
| Sep 30 2021 | n/a | n/a | -CN¥436m |
| Jun 30 2021 | n/a | n/a | -CN¥285m |
| Mar 31 2021 | n/a | n/a | CN¥277m |
| Dec 31 2020 | CN¥756k | CN¥229k | CN¥839m |
| Sep 30 2020 | n/a | n/a | CN¥1b |
| Jun 30 2020 | n/a | n/a | CN¥2b |
| Mar 31 2020 | n/a | n/a | CN¥2b |
| Dec 31 2019 | CN¥393k | CN¥222k | CN¥2b |
| Sep 30 2019 | n/a | n/a | CN¥2b |
| Jun 30 2019 | n/a | n/a | CN¥1b |
| Mar 31 2019 | n/a | n/a | CN¥1b |
| Dec 31 2018 | CN¥365k | CN¥209k | CN¥943m |
| Sep 30 2018 | n/a | n/a | CN¥961m |
| Jun 30 2018 | n/a | n/a | CN¥980m |
| Mar 31 2018 | n/a | n/a | CN¥813m |
| Dec 31 2017 | CN¥324k | CN¥194k | CN¥647m |
Compensazione vs Mercato: La retribuzione totale di Juncai ($USD 354.98K ) è circa la media per le aziende di dimensioni simili nel mercato Hong Kong ($USD 481.54K ).
Compensazione vs guadagni: La retribuzione di Juncai è aumentata di oltre il 20% nell'ultimo anno.
AMMINISTRATORE DELEGATO
Juncai Jiang (42 yo)
9.5yrs
Mandato
CN¥2,572,000
Compensazione
Mr. Juncai Jiang has been General Manager and Executive Director of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. since joining in May 2015. Mr. Jiang served as Deputy Head of the traditional Chinese med...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| GM & Executive Director | 9.5yrs | CN¥2.57m | 0.0076% HK$ 623.8k | |
| Head of the Sales Department | 10.5yrs | CN¥645.00k | Nessun dato | |
| Deputy GM & Executive Director | 9.5yrs | CN¥2.71m | 0.0076% HK$ 627.9k | |
| Deputy GM & Executive Director | 9.5yrs | CN¥1.32m | 0.0076% HK$ 623.8k | |
| Executive Director | 1.2yrs | CN¥1.59m | Nessun dato | |
| CFO & Head of Finance Department | 5.8yrs | CN¥480.38k | Nessun dato | |
| Chief of Quality Division & Employee Representative Supervisor | 7.3yrs | Nessun dato | 0.0036% HK$ 299.2k | |
| Joint Company Secretary | 6.1yrs | CN¥370.31k | Nessun dato | |
| Joint Company Secretary | 2.8yrs | Nessun dato | Nessun dato |
7.3yrs
Durata media
43yo
Età media
Gestione esperta: Il team dirigenziale di 1558 è esperto e expertise (durata media dell'incarico 7.3 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| GM & Executive Director | 9.5yrs | CN¥2.57m | 0.0076% HK$ 623.8k | |
| Deputy GM & Executive Director | 18.8yrs | CN¥2.71m | 0.0076% HK$ 627.9k | |
| Deputy GM & Executive Director | 6.4yrs | CN¥1.32m | 0.0076% HK$ 623.8k | |
| Executive Director | 1.2yrs | CN¥1.59m | Nessun dato | |
| Chief of Quality Division & Employee Representative Supervisor | 7.3yrs | Nessun dato | 0.0036% HK$ 299.2k | |
| Non-Executive Chairman | 9.5yrs | CN¥32.19m | 0.015% HK$ 1.2m | |
| Independent Non-Executive Director | 9.5yrs | CN¥100.00k | Nessun dato | |
| Supervisor | 7.4yrs | Nessun dato | 0.0076% HK$ 623.8k | |
| Chairman of the Board of Supervisors | 5.4yrs | Nessun dato | Nessun dato | |
| Independent Non Executive Director | 4.4yrs | CN¥100.00k | Nessun dato | |
| Independent Non-Executive Director | 4.2yrs | CN¥340.00k | 0.00045% HK$ 37.0k |
7.3yrs
Durata media
46yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 1558 sono considerati esperti (durata media dell'incarico 7.3 anni).